YTHDF2 and gastric cancer: However, through Gene Set Enrichment Analysis (GSEA) and external experiments such as quantification of m6A methylation and western blot assay, YTHDF2 was found to be a potential tumor inhibitory factor, and high YTHDF2 expression was correlated with the prolonged survival time of GC patients [45].